NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
June 2, 2026 — Apple and wearable-device developers benefit as AI and edge computing turn wearables into clinical tools for real-time insights, remote monitoring, and improved healthcare access.
June 2, 2026 — Regentis Biomaterials advances GelrinC, a cell-free hydrogel for knee cartilage repair, targeting 470K US cases. Phase III trial over 50% enrolled with superior pain relief vs microfracture.
June 2, 2026 — By 2050, 6 in 10 U.S. women may have cardiovascular disease, driven by rising obesity, diabetes, and high blood pressure. Learn prevention tips from the American Heart Association's Life's Essential 8.
June 2, 2026 — Regentis Biomaterials' GelrinC(R) platform targets $3B knee cartilage market with off-the-shelf, single-step procedure. Clinical data shows 100% greater pain improvement vs microfracture. Phase III trial underway.
June 2, 2026 — Razi Orthodontics offers expert Invisalign in Naperville IL with free consultations. Specialized orthodontic care for adults and teens seeking clear aligners.
June 2, 2026 — Mia Orthodontics, led by Dr. Alireza Hourfar, opens in Upper Kirby Houston, offering braces and Invisalign with board-certified personalized care for all ages.
June 2, 2026 — Seaport Orthodontics opens in Manhattan's Seaport district, offering Invisalign, braces, and early treatment. Free consultations available for new patients.
June 2, 2026 — Oncotelic Therapeutics (OTLC) featured in BioMedWire editorial on advanced drug delivery technologies, including nanoparticle systems and AI platforms, aiming to improve cancer therapy efficacy and patient outcomes.
June 2, 2026 — Quantum BioPharma (NASDAQ: QNTM) enters investor relations agreement with Stocks.news via IR Agency LLC for US$250K. Focus on Lucid-MS for MS and UNBUZZD royalty stream. Boost visibility for neurodegenerative therapies.
June 2, 2026 — Oncotelic Therapeutics (OTLC) featured in BioMedWire editorial on advanced drug delivery technologies, including nanoparticle systems and AI platforms, to enhance cancer therapies. Read the full press release.
June 2, 2026 — Lantern Pharma's LP-300 shows improved progression-free survival in EGFR L858R-mutant lung cancer patients. Updated Phase 2 HARMONIC trial data supports extended dosing. AI-driven precision oncology.
June 2, 2026 — Inhaled viral vector boosts anti-cancer response in advanced lung cancer, restores sensitivity to immune checkpoint inhibitors. Learn about this breakthrough from BioMedWire.
June 2, 2026 — Quantum BioPharma (QNTM) discusses Lucid-MS for MS mobility loss and unbuzzd(TM) alcohol metabolism product on The BioMedWire Podcast. Phase 2 trial upcoming.
June 2, 2026 — Quantum BioPharma (QNTM) discusses Lucid-MS for multiple sclerosis and unbuzzd(TM) alcohol metabolism product on BioMedWire Podcast. Phase 2 trial upcoming.
June 2, 2026 — Ocumetics Technology Corp. converts $1.4M debenture principal to shares, reducing debt by 35% and strengthening balance sheet ahead of FDA IDE submission and patient study milestones.
June 2, 2026 — HeartBeam's risk prediction algorithm using credit card-sized ECG device achieves 92.9% AUC for heart attack detection. Study in JACC: Advances supports future indication for HeartBeam System.
June 2, 2026 — LataMed AI finalizes exclusive interview with Hablemos Seguros & Finanzas to discuss digital health strategy, telehealth infrastructure, and AI solutions for Latin America.
June 1, 2026 — Regentis Biomaterials advances GelrinC®, a cell-free hydrogel implant for knee cartilage repair, targeting a $3B U.S. market with Phase III trial progress and CE Mark approval.
June 1, 2026 — American Heart Association and Houston Texans train youth coaches in CPR and AED use to combat cardiac arrest in young athletes, aiming to double survival rates by 2030.
June 1, 2026 — Encinitas Pediatric Dentistry & Orthodontics launches integrated care model combining pediatric dentistry and orthodontics under one roof for children, teens, and adults. Offers braces, Invisalign, and clear aligners.